LON:GDR - Genedrive Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Genedrive PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 9 0.00 (0.00 %) (As of 02/26/2020 04:00 PM ET) Add Compare Today's Range 8Now: GBX 9▼ 8.0450-Day Range 7MA: GBX 15.85▼ 21.5052-Week Range 6.25Now: GBX 9▼ 28Volume298,101 shsAverage Volume9,606 shsMarket Capitalization£3.14 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartEarningsInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. It operates through three divisions: Preclinical Research Services, Pharmacogenomic Services, and Diagnostics. The Preclinical Research Services division provides pre-clinical testing services in the areas of oncology, oncology supportive care, inflammatory bowel disease, leukaemia, gastrointestinal disease, inflammation, skin care and wound healing, and rheumatoid arthritis. Read More… Industry, Sector and Symbol Stock Exchange LON Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolLON:GDR Previous SymbolLON:EHP CUSIPN/A CIKN/A Webhttp://www.genedriveplc.com/ Phone+44-161-9890245Debt Debt-to-Equity RatioN/A Current Ratio4.11 Quick Ratio3.90Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£1.50 million Price / Sales2.09 Cash FlowGBX 10 per share Price / Cash Flow0.90 Book ValueGBX (15.80) per share Price / Book-0.57Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees72 Outstanding Shares34,870,100Market Cap£3.14 million Next Earnings DateN/A OptionableNot Optionable Receive GDR News and Ratings via Email Sign-up to receive the latest news and ratings for GDR and its competitors with MarketBeat's FREE daily newsletter. LSE:GDR Rates by TradingView Genedrive (LON:GDR) Frequently Asked Questions What is Genedrive's stock symbol? Genedrive trades on the London Stock Exchange (LON) under the ticker symbol "GDR." How were Genedrive's earnings last quarter? Genedrive PLC (LON:GDR) announced its quarterly earnings results on Tuesday, February, 4th. The company reported ($8.90) earnings per share (EPS) for the quarter. View Genedrive's Earnings History. What is the consensus analysts' recommendation for Genedrive? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genedrive in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Genedrive. Has Genedrive been receiving favorable news coverage? Media headlines about GDR stock have been trending somewhat positive this week, according to InfoTrie. The research firm identifies positive and negative media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Genedrive earned a media sentiment score of 1.1 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 3.0 out of 10, meaning that recent media coverage is unlikely to have an impact on the stock's share price in the near term. View News Stories for Genedrive. Who are some of Genedrive's key competitors? Some companies that are related to Genedrive include Dorsavi (DVL), VentriPoint Diagnostics (VPT), Cambridge Cognition (COG), Smiles Inclusive (SIL), Lifespot Health (LSH), Cryosite (CTE), 3D Signatures (DXD), Imaging Dynamics (IDL), Med Biogene (MBI), BioMark Diagnostics (BUX), Carl Data Solutions (CRL), EPIGENOMICS AG/S (EPGNY), Eternity Healthcare (ETAH), Imagin Medical (IME) and Medical Imaging (MEDD). What other stocks do shareholders of Genedrive own? Based on aggregate information from My MarketBeat watchlists, some companies that other Genedrive investors own include NVIDIA (NVDA), Allena Pharmaceuticals (ALNA), Chuy's (CHUY), Comtech Telecomm. (CMTL), Cisco Systems (CSCO), FormFactor (FORM), Hub Group (HUBG), Mondelez International (MDLZ), Methanex (MEOH) and Manitex International (MNTX). Who are Genedrive's key executives? Genedrive's management team includes the folowing people: Mr. David Budd, CEO & Director (Age 51)Mr. Matthew J. Fowler, CFO, Company Sec. & Director (Age 44) How do I buy shares of Genedrive? Shares of GDR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Genedrive's stock price today? One share of GDR stock can currently be purchased for approximately GBX 9. How big of a company is Genedrive? Genedrive has a market capitalization of £3.14 million and generates £1.50 million in revenue each year. Genedrive employs 72 workers across the globe.View Additional Information About Genedrive. What is Genedrive's official website? The official website for Genedrive is http://www.genedriveplc.com/. How can I contact Genedrive? Genedrive's mailing address is 48 Grafton Street, MANCHESTER, M13 9XX, United Kingdom. The company can be reached via phone at +44-161-9890245. MarketBeat Community Rating for Genedrive (LON GDR)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 223 (Vote Outperform)Underperform Votes: 172 (Vote Underperform)Total Votes: 395MarketBeat's community ratings are surveys of what our community members think about Genedrive and other stocks. Vote "Outperform" if you believe GDR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GDR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/26/2020 by MarketBeat.com StaffFeatured Article: Google Finance Portfolio
